Wealth Effects »

Humacyte shares owned by Wealth Effects

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Wealth Effects from 13F filings

Historical chart of Wealth Effects investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Wealth Effects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Wealth Effects

Quarter filed Position value Share count Share price at filing
2024-09-30 $349k 64k 5.44

More positions owned by Wealth Effects

Avadel Pharmaceuticals Com Shs (AVDL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
The Trade Desk Com Cl A (TTD)
Alphabet Cap Stk Cl A (GOOGL)
Blackstone Group Inc Com Cl A (BX)
Impinj (PI)
International Business Machines (IBM)
Arrowhead Pharmaceuticals (ARWR)
United Rentals (URI)

View all positions for Wealth Effects

Top funds holding Humacyte

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Voloridge Investment Management
Nuveen Asset Management
Two Sigma Investments
Susquehanna International
Woodline Partners
Northern Trust
Goldman Sachs Group
Charles Schwab Investment Management
Marshall Wace
Monashee Investment Management

View all funds holding Humacyte